PHARMACOKINETICS AND EXPOSURE-RESPONSE RELATIONSHIPS OF INTRAVENOUSLY ADMINISTERED USTEKINUMAB DURING INDUCTION TREATMENT IN PATIENTS WITH ULCERATIVE COLITIS: RESULTS FROM THE UNIFI INDUCTION STUDY

被引:0
|
作者
Adedokun, Omoniyi J.
Xu, Zhenhua
Marano, Colleen W.
O'Brien, Christopher D.
Szapary, Philippe
Zhang, Hongyan
Johanns, Jewel
Leong, Rupert W.
Hisamatsu, Tadakazu
Van Assche, Gert A.
Danese, Silvio
Abreu, Maria T.
Sands, Bruce E.
Sandborn, William J.
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Tu1749
引用
收藏
页码:S1110 / S1110
页数:1
相关论文
共 50 条
  • [1] Pharmacokinetics and exposure-response relationships of intravenously administered ustekinumab during induction treatment in patients with ulcerative colitis: Results from the UNIFI induction study
    Adedokun, O. J.
    Xu, Z.
    Marano, C.
    O'Brien, C. D.
    Szapary, P.
    Zhang, H.
    Johanns, J.
    Leong, R. W.
    Hisamatsu, T.
    Van Assche, G.
    Danese, S.
    Abreu, M. T.
    Sands, B. E.
    Sandborn, W. J.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S255 - S256
  • [2] Pharmacokinetics and exposure-response relationships of intravenously administered ustekinumab during induction treatment in patients with ulcerative colitis: Results from the UNIFI induction study
    Adedokun, O.
    Xu, Z.
    Marano, C.
    O'Brien, C.
    Szapary, P.
    Zhang, H.
    Johanns, J.
    Leong, R.
    Hisamatsu, T.
    Van Assche, G.
    Danese, S.
    Abreu, M.
    Sands, B.
    Sandborn, W.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 147 - 147
  • [3] Pharmacokinetics and Exposure-Response Relationships of Ustekinumab in Patients With Ulcerative Colitis: Results From the UNIFI Induction and Maintenance Studies
    Adedokun, Omoniyi J.
    Xu, Zhenhua
    Marano, Colleen
    O'Brien, Christopher
    Szapary, Philippe
    Zhang, Hongyan
    Johanns, Jewel
    Leong, Rupert W. L.
    Hisamatsu, Tadakazu
    Van Assche, Gert
    Danese, Silvio
    Abreu, Maria T.
    Sands, Bruce E.
    Sandborn, William J.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S481 - S482
  • [4] Pharmacokinetics and exposure-response relationships of intravenously administered ustekinumab during induction treatment in patients with Crohn's disease: results from the UNITI-1 and UNITI-2 studies
    Adedokun, O. J.
    Xu, Z.
    Gasink, C.
    Friedman, J.
    Szapary, P.
    Lang, Y.
    Johanns, J.
    Gao, L. -L.
    Miao, Y.
    Davis, H.
    Hanauer, S.
    Feagan, B.
    Sandborn, W.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S23 - S24
  • [5] Early Improvement After Intravenous Ustekinumab Induction in Patients With Ulcerative Colitis: Results From the UNIFI Induction Trial
    Sands, Bruce E.
    Abreu, Maria T.
    Marano, Colleen
    Baker, Thomas
    O'Brien, Christopher
    Zhang, Hongyan
    Johanns, Jewel
    Rowbotham, David
    Leong, Rupert W. L.
    Danese, Silvio
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S404 - S404
  • [6] Upadacitinib Population Pharmacokinetics and Exposure-Response Relationships in Ulcerative Colitis Patients
    Ana Victoria Ponce-Bobadilla
    Sven Stodtmann
    Doerthe Eckert
    Wen Zhou
    Wei Liu
    Mohamed-Eslam F. Mohamed
    Clinical Pharmacokinetics, 2023, 62 : 101 - 112
  • [7] Upadacitinib Population Pharmacokinetics and Exposure-Response Relationships in Ulcerative Colitis Patients
    Ponce-Bobadilla, Ana Victoria
    Stodtmann, Sven
    Eckert, Doerthe
    Zhou, Wen
    Liu, Wei
    Mohamed, Mohamed-Eslam F.
    CLINICAL PHARMACOKINETICS, 2023, 62 (01) : 101 - 112
  • [8] Exposure-response relationship during vedolizumab induction therapy in adults with ulcerative colitis
    Rosario, M.
    French, J.
    Dirks, N.
    Milton, A.
    Fox, I.
    Gastonguay, M.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S270 - S271
  • [9] EFFICACY AND SAFETY OF USTEKINUMAB THROUGH WEEK 16 IN PATIENTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS RANDOMIZED TO USTEKINUMAB: RESULTS FROM THE UNIFI INDUCTION TRIAL
    Danese, Silvio
    Sands, Bruce E.
    O'Brien, Christopher D.
    Zhang, Hongyan
    Johanns, Jewel
    Sloan, Sheldon
    Izanec, James L.
    Szapary, Philippe
    Marano, Colleen W.
    Leong, Rupert W.
    Rowbotham, David
    Targan, Stephan R.
    Van Assche, Gert A.
    GASTROENTEROLOGY, 2019, 156 (06) : S1106 - S1106
  • [10] MIRIKIZUMAB PHARMACOKINETICS AND EXPOSURE-RESPONSE RELATIONSHIPS IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM RANDOMISED PHASE 2 AND PHASE 3 INDUCTION AND MAINTENANCE TRIALS
    Friedrich, Stuart
    Chua, Laiyi
    Zhang, Xin
    GASTROENTEROLOGY, 2023, 164 (06) : S1217 - S1218